MediLedger is an innovative, industry-led, blockchain-powered network and platform for the life sciences industry, specifically targeting Pharmaceutical Manufacturers, Distributors, Group Purchasing Organizations (GPOs), and Health Systems. It was established in 2017 to address complex industry challenges, including compliance with the Drug Supply Chain Security Act (DSCSA) and inefficiencies in contract and chargeback management.
The platform's core value proposition is to enable trust and automation between trading partners through a decentralized, permissioned blockchain network. This architecture allows all network participants to have access to the same, consistent data—such as contract pricing and customer eligibility—in real-time, without needing to share proprietary business intelligence. This is achieved using advanced cryptographic techniques like Zero-Knowledge Proofs (zk-SNARKs) to ensure strict transactional privacy while maintaining data immutability and integrity.
Key Solutions & Capabilities:
- Roster Management: Provides validated GPO rosters and ensures health system site alignment on customer eligibility.
- Contract Communication: Enables real-time contract alignment and communication of updates.
- Claim Adjudication: Enforces chargeback accuracy and automates the chargeback process, reducing errors and disputes.
- 340B Solutions: Helps ensure accurate 340B claims.
- DSCSA Product Verification: Supports compliance with DSCSA requirements for track and trace of prescription medicines, verifying product authenticity and provenance.
By leveraging this network, companies can significantly reduce revenue leakage from ineligible chargebacks, eliminate costly pricing discrepancies and rebills, and cut manual workload, ultimately optimizing Gross-to-Net (GTN) revenue and fostering a more resilient healthcare ecosystem.